Elevated myeloperoxidase activity in white matter in multiple sclerosis

[1]  W. Brück,et al.  Interplay between mechanisms of damage and repair in multiple sclerosis , 2008, Journal of Neurology.

[2]  S. Love,et al.  Elevated Activity and Microglial Expression of Myeloperoxidase in Demyelinated Cerebral Cortex in Multiple Sclerosis , 2008, Brain pathology.

[3]  H. Lassmann,et al.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? , 2007, Brain : a journal of neurology.

[4]  Bruce D. Trapp,et al.  Pathogenesis of axonal and neuronal damage in multiple sclerosis , 2007, Neurology.

[5]  J. Kira,et al.  Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity , 2006, Journal of Neuroimmunology.

[6]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[7]  E. V. van Tol,et al.  Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease. , 2004, Biochemical pharmacology.

[8]  Wolfgang Brück,et al.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.

[9]  Kenneth J. Smith,et al.  Electrically active axons degenerate when exposed to nitric oxide , 2001, Annals of neurology.

[10]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[11]  E. Masliah,et al.  Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease , 1999, Experimental Neurology.

[12]  Kenneth J. Smith,et al.  Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.

[13]  E. Benveniste,et al.  Cytokine actions in the central nervous system. , 1998, Cytokine & growth factor reviews.

[14]  D. Roos,et al.  Reactive oxygen species are required for the phagocytosis of myelin by macrophages , 1998, Journal of Neuroimmunology.

[15]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[16]  B. Becher,et al.  Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis , 1997, Journal of Neuroimmunology.

[17]  R. Hohlfeld,et al.  Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.

[18]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[19]  Christine D. Dijkstra,et al.  Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats , 1995, Journal of Neuroimmunology.